NASDAQ:ELAB PMGC (ELAB) Stock Price, News & Analysis $1.25 -0.07 (-4.92%) As of 02:44 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesSEC FilingsTrendsBuy This Stock About PMGC Stock (NASDAQ:ELAB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get PMGC alerts:Sign Up Key Stats Today's Range$1.24▼$1.3450-Day Range$1.32▼$5.0852-Week Range$1.24▼$309.12Volume171,067 shsAverage Volume4.47 million shsMarket Capitalization$1.45 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California. Read More PMGC Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks3rd Percentile Overall ScoreELAB MarketRank™: PMGC scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.5 / 5Analyst RatingSell Consensus RatingPMGC has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoveragePMGC has received no research coverage in the past 90 days.Read more about PMGC's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of PMGC is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of PMGC is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPMGC has a P/B Ratio of 0.01. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted51.81% of the float of PMGC has been sold short.Short Interest Ratio / Days to CoverPMGC has a short interest ratio ("days to cover") of 0.39, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in PMGC has recently increased by 55.80%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPMGC does not currently pay a dividend.Dividend GrowthPMGC does not have a long track record of dividend growth. News and Social Media0.6 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 2 news articles for PMGC this week, compared to 3 articles on an average week.Search Interest6 people have searched for ELAB on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days. Company Ownership0.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, PMGC insiders have not sold or bought any company stock.Percentage Held by Insiders0.01% of the stock of PMGC is held by insiders.Percentage Held by Institutions22.22% of the stock of PMGC is held by institutions.Read more about PMGC's insider trading history. Receive ELAB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PMGC and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ELAB Stock News HeadlinesHead-To-Head Analysis: People Incorporated Common Stock (NASDAQ:PPLI) and PMGC (NASDAQ:ELAB)June 21 at 4:17 AM | americanbankingnews.comNorthStrive Biosciences Files Two New U.S. Patent Applications Targeting Muscle Preservation in GLP-1 and Next-Generation Obesity Treatment MarketsJune 18, 2026 | globenewswire.comA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.June 24 at 1:00 AM | Porter & Company (Ad)PMGC Holdings Highlights Advanced Precision Manufacturing Capabilities Supporting Space Exploration Supply ChainsJune 10, 2026 | globenewswire.comPMGC Holdings Shareholders Approve Governance-Related Bylaw AmendmentsJune 8, 2026 | tipranks.comNorthStrive Defense Tech Executes Binding Agreement to Acquire Exclusive License to Patented Multi-Domain Drone Payload Technology for Defense, Aerospace and Maritime ApplicationsJune 8, 2026 | globenewswire.comPMGC Holdings Signs Non-Binding Letter of Intent to Acquire Majority Stake in U.S.-Based Precision Machining Manufacturing Company Serving Aerospace, Space, Defense, and ...June 2, 2026 | markets.businessinsider.comWhy Is ELAB Stock Rising Today?June 2, 2026 | finance.yahoo.comSee More Headlines ELAB Stock Analysis - Frequently Asked Questions How have ELAB shares performed this year? PMGC's stock was trading at $35.52 at the beginning of the year. Since then, ELAB shares have decreased by 96.5% and is now trading at $1.2550. How were PMGC's earnings last quarter? PMGC Holdings Inc. (NASDAQ:ELAB) released its quarterly earnings results on Thursday, May, 14th. The company reported ($11.22) earnings per share (EPS) for the quarter. The business had revenue of $0.68 million for the quarter. When did PMGC's stock split? PMGC's stock reverse split on the morning of Tuesday, March 10th 2026.The 1-6 reverse split was announced on Wednesday, March 4th 2026. The number of shares owned by shareholders was adjusted after the closing bell on Monday, March 9th 2026. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split. When did PMGC IPO? PMGC (ELAB) raised $6 million in an initial public offering on Tuesday, November 21st 2023. The company issued 1,500,000 shares at $4.00 per share. Univest Securities served as the underwriter for the IPO. How do I buy shares of PMGC? Shares of ELAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of PMGC own? Based on aggregate information from My MarketBeat watchlists, some other companies that PMGC investors own include BIOLASE (BIOL), CDT Equity (CDT), Cyclacel Pharmaceuticals (CYCC), Dare Bioscience (DARE), TRACON Pharmaceuticals (TCON), Tempest Therapeutics (TPST) and 22nd Century Group (XXII). Company Calendar Last Earnings5/14/2026Today6/24/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2m+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 ELAB's financial health is in the Yellow zone, according to TradeSmith. ELAB has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMulti-Sector Conglomerates Industry DIVERSIFIED OPS Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:ELAB Previous SymbolNASDAQ:ELAB CIK1840563 Webelevaiskincare.com Phone866-794-4940FaxN/AEmployees18Year FoundedN/AProfitability EPS (Trailing Twelve Months)($168.62) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$7.75 million Net MarginsN/A Pretax Margin-877.04% Return on Equity-117.82% Return on Assets-70.79% Debt Debt-to-Equity Ratio0.03 Current Ratio1.45 Quick Ratio1.43 Sales & Book Value Annual Sales$1.27 million Price / Sales1.14 Cash FlowN/A Price / Cash FlowN/A Book Value$93.33 per share Price / Book0.01Miscellaneous Outstanding Shares1,159,000Free Float1,159,000Market Cap$1.45 million OptionableN/A Beta-0.27 The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:ELAB) was last updated on 6/24/2026 by MarketBeat.com Staff. From Our PartnersQuick favor to ask youBill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...Profits Run | SponsoredMy feud with Zohran MamdaniNearly 40% of Americans now hold a positive view of socialism - and former hedge fund manager Whitney Tilson s...Stansberry Research | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | SponsoredVWAV: An Under-the-Radar Defense PlayVisionWave Holdings (NASDAQ: VWAV) is developing a multi-domain defense platform combining AI-powered analytic...Equiscreen | SponsoredThe Treasury just bought its own debtOn April 16th, the U.S. Treasury executed a $15 billion buyback of its own debt - the largest in history - whi...Golden Portfolio | SponsoredMarket Legend DUMPS 537,742 Nvidia Shares...One of the most influential tech investors of all time just sold 537,742 shares of Nvidia - along with his ent...InvestorPlace | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredElon Is Quietly Doubling Down on This Bizarre AssetYahoo Finance reports this technology 'May Unlock $400 Trillion' - and Bloomberg calls it 'unavoidable.' Elon ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PMGC Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PMGC With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
